24
How drugs work? Or How do they ‘know’ to go from my stomach to my head and not my foot?

Basic biopharmaceutics, pharmacokinetics, pharmacodynamics

Embed Size (px)

Citation preview

Page 1: Basic biopharmaceutics, pharmacokinetics, pharmacodynamics

How drugs work?Or

How do they ‘know’ to go from my stomach to my head

and not my foot?

Page 2: Basic biopharmaceutics, pharmacokinetics, pharmacodynamics

Basic Biopharmaceutics

Page 3: Basic biopharmaceutics, pharmacokinetics, pharmacodynamics

Objective of Drug Therapy

To deliver the right drug, in the right concentration, to the right site of action and at the right time to produce the desired effect.

(of course in the right patient!)

Page 4: Basic biopharmaceutics, pharmacokinetics, pharmacodynamics

Clinical Trials 10-15 years from lab to US patients Only 1 in 5000 compounds make it to human

testing Only 1 in 5 tested in humans is approved Testing Phases in Humans

Phase I (ADME) Phase II (w/dz) Phase III (Special study) Phase IV (post-mkt)

Page 5: Basic biopharmaceutics, pharmacokinetics, pharmacodynamics
Page 6: Basic biopharmaceutics, pharmacokinetics, pharmacodynamics

Generic Medications Patent on parent agent Hatch-Waxman Act 1984 Pharmaceutical Co

ANDA filed with FDA Bioequivalent Labeling Review

Pharmaceutically equiv. Therapeutically equiv.

Page 7: Basic biopharmaceutics, pharmacokinetics, pharmacodynamics

Types of Drug Action

React physically

React chemically

Modify metabolic activity & enzyme systems

Change osmolarity of blood

Interfere with normal cell function

Modify ion channels

Modify creation, release or control of neurotransmitters or hormones

Page 8: Basic biopharmaceutics, pharmacokinetics, pharmacodynamics

Receptors

Cellular material at the site of action

Lock & keyAgonist

Antagonist

The Love Cocktail

Page 9: Basic biopharmaceutics, pharmacokinetics, pharmacodynamics

Concentration & Effect

Blood concentration – time profileMEC minimum effective concentration

MTC minimum toxic concentration

Onset of action

Therapeutic window

Duration of action

Half-life• The time taken for the drug

Concentration to decline by 50%

Page 10: Basic biopharmaceutics, pharmacokinetics, pharmacodynamics

….OR

The time taken for 50% of the drug to be eliminatedThe time taken for the drug concentration to fall to half the original value

After 4 half lives, elimination is 94% completeAfter 7 half lives, elimination is 99% complete

After 1 half life, elimination is_____complete

Page 11: Basic biopharmaceutics, pharmacokinetics, pharmacodynamics
Page 12: Basic biopharmaceutics, pharmacokinetics, pharmacodynamics
Page 13: Basic biopharmaceutics, pharmacokinetics, pharmacodynamics

Bioequivalence Terms

Bioavailability

Bioequivalency

Pharmaceutical equivalent

Pharmaceutical alternative

Therapeutic equivalent

Page 14: Basic biopharmaceutics, pharmacokinetics, pharmacodynamics

Pharmacokinetics Pharmacodynamics

How a drug MovesWhat the body does to a drugADME

AbsorptionDistributionMetabolismExcretion

DiffusionPassive diffusionActive transport

How a drug BehavesWhat the drug does to the body

BeneficialToxic

Page 15: Basic biopharmaceutics, pharmacokinetics, pharmacodynamics

Absorption Distribution

Gastric emptying

Intestinal movement rate

Blood flow rate

Permeability of tissue membranes

Protein binding

Page 16: Basic biopharmaceutics, pharmacokinetics, pharmacodynamics

Metabolism Excretion

LiverEnzyme induction

Enzyme inhibition

Gall bladderStores metabolites

Enterohepatic cycling

First-Pass metabolism

KidneysNephron

Glomerular filtration rate

Page 17: Basic biopharmaceutics, pharmacokinetics, pharmacodynamics

Factors Affecting Drug Response

Age

Gender

Pregnancy

Genetics

Body weight

Psychological factors

Page 18: Basic biopharmaceutics, pharmacokinetics, pharmacodynamics

Adverse Drug Reactions

CNS effects

Hepatotoxicity

Hypersensitivity or Allergy

GI effects

Nephrotoxicity

Hematological effects

Drug dependence

Teratogenicity

Carcinogenicity

Idiosyncrasy

Page 19: Basic biopharmaceutics, pharmacokinetics, pharmacodynamics

Drug-Drug Interactions

Absorption Distribution Metabolism Excretion

Binding in GIT

GI empty

Displacemt

and effect

Enzyme induction

GFR

Renal Secretion

Gastric pH

Intestinal

Metabolism

Enzyme inhibition

Urinary Re-absorption

Page 20: Basic biopharmaceutics, pharmacokinetics, pharmacodynamics

Drug-Diet Interactions

Absorption Distribution Metabolism Excretion

Gastric emptying

Gastric motility

Dosage form

Interacting chemically

FoodHi fat meals

Level of nourishment

AdminTime

Food MixProtein

Carbohydrate

Fat

Calories

ProteinInc.GFR

Dec.reabsorption

Dec.secretion in the kidney

Page 21: Basic biopharmaceutics, pharmacokinetics, pharmacodynamics

Drug Disease States

Hepatic Circulatory Renal Thyroid

Cirrhosis

Obstructive jaundice

Acute viral hepatitis

Cardiovascular Disorders

Decrease Blood Flow

erratic absorptn

liver metabolm

Effect on drug elimination

Effect on plasma protein binding

Creatinine levels

Hypo- Hyper-

Page 22: Basic biopharmaceutics, pharmacokinetics, pharmacodynamics

Types of drug actionReceptors

Concentration & effect

Pharmacokinetics & dynamics• Absorption, distribution,metabolism, excretion

• Factors affecting drug responses

Adverse drug reactionsInteractions

CASE STUDY!

Page 23: Basic biopharmaceutics, pharmacokinetics, pharmacodynamics

Precipitating Event 1st Week SRJC Professional Program

35yr old, average wt to ht male presents to clinic with facial flushing, anxiety, palpitations, mild temporal HA

Hx: S/P Hep C in remission

Personal Hx: unremarkable

Social Hx: smokes ½ ppd, coffee 4-6 cups

Drinks tangerine juice with a splash of lime

VS: BP 146/90 P 99 T normal

Page 24: Basic biopharmaceutics, pharmacokinetics, pharmacodynamics

MED List: APAP 1000mg qid prn HA, Mylanta prn gastritis, Inderal 20mg BID,

OTC herbal aphrodisiac

Dx: anxiety reaction frequently ppts migraine

POINTS TO PONDERTreatment plan?

Lifestyle modifications?

Pharmacokinetics?

Factors altering drug response?